By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they ...

Millions of children worldwide have been left vulnerable to preventable diseases, including measles, polio, and tuberculosis, ...

The Gates Foundation has announced a new commitment of US$1.6 billion over the next five years to support Gavi, the ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria vaccine for children 'RTS,S' developed by GSK, PATH and partners, by more than ...